Hepatitis Now: Expanding HBV Treatment Candidacy

On June 18, join us for the third Webinar in a series reviewing best practices and emerging data in viral hepatitis!

In this live, 45-minute, CME/CE/CPE-certified Webinar, Ira M. Jacobson, MD, will review criteria for initiating HBV therapy, recommended monitoring in patients not currently receiving antivirals, and opportunities to broaden candidacy for treatment.


Welcome and Program Overview

  • AASLD Guidance on Initiation of HBV Therapy
  • Active Monitoring of Patients Not Currently Receiving Antivirals
  • Opportunities to Broaden Treatment Candidacy

Question and Answer Session


Date / Time
Event Details


Ira Jacobson, MD

Director of Hepatology
Department of Medicine
NYU School of Medicine
New York, New York

Goal Statement
The goal of this activity is to improve participants’ confidence and competence in incorporating best practices and emerging data into their patient care strategies for patients with hepatitis B.

Target Audience 
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals involved in the management of patients with hepatitis B.

Learning Objective

  • Implement updated strategies in identifying candidates for treatment of HBV infection based on published data and expert guidelines


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this activity is 0.75 contact hour.

Pharmacist Continuing Education
CCO designates this continuing education activity for 0.75 contact hour (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-19-023-L01-P.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.